Jacobs Levy Equity Management’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
Jacobs Levy Equity Management's WGS Position: Q2 2026 in Review
Jacobs Levy Equity Management reduced its GeneDx Holdings (WGS) stake by 4.4% in Q2 2026, selling an estimated $37.7K and leaving 14,281 shares worth $980K. The position accounts for ﹤0.01% of the portfolio, ranked #711.
Jacobs Levy Equity Management first reported a position in WGS in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.28M in Q2 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Jacobs Levy Equity Management held 14,281 shares of GeneDx Holdings worth $980K as of Q2 2026.
- Jacobs Levy Equity Management sold 663 GeneDx Holdings shares in Q2 2026, an estimated $37.7K.
- GeneDx Holdings made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #711 holding.
- Jacobs Levy Equity Management first reported a position in GeneDx Holdings in Q4 2023 and has held it in 10 quarters since.
- Jacobs Levy Equity Management's GeneDx Holdings position peaked at $5.28M in Q2 2024.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.